Amgen British Columbia
Records under this name other than patents Amgen British Columbia holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Amgen British Columbia
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,779,108 | Targeted Binding Agents Against B7-H1 Formerly held In force · High confidence | In force | High confidence | |
| US 10,400,039 | Targeted Binding Agents Against B7-H1 Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,518,809 | Targeted Binding Agents Against B7-H1 Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,941,211 | Anti-Gcc Antibody Molecules and Related Compositions and Methods Formerly held In force · High confidence | In force | High confidence | |
| US 9,493,565 | Targeted Binding Agents Against B7-H1 Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,785,600 | Anti-Gcc Antibody Molecules and Related Compositions and Methods Formerly held In force · High confidence | In force | High confidence | |
| US 8,119,130 | Targeted Binding Agents Directed to KDR and Uses Thereof - 035 Formerly held Lapsed on the fee record Ended Feb 21, 2024 · High confidence | Lapsed on the fee record | Ended Feb 21, 2024 | High confidence |